UPDATE 1-U.S. FDA panel split over approval of Durect's non-opioid painkiller
January 16, 2020 at 15:22 PM EST
Independent experts on an FDA advisory panel on Thursday were split over the approval of Durect Corp's non-opioid painkiller to manage post-surgical pain.
